Oral Immunization with RecombinantStreptococcus gordonii Expressing Porphyromonas gingivalis FimA Domains

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Infection and Immunity

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.69.5.2928-2934.2001PMID 11292708PMCID PMC98244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunogenicity of the B Monomer ofEscherichia coli Heat-Labile Toxin Expressed on the Surface of Streptococcus gordonii

  2000cited by this paper
• Coimmunization with Complementary Glucosyltransferase Peptides Results in Enhanced Immunogenicity and Protection against Dental Caries

  2000cited by this paper
• Role of the Amino-Terminal Region ofPorphyromonas gingivalis Fimbriae in Adherence to Epithelial Cells

  1999cited by this paper
• Expression of saliva-binding epitopes of the Porphyromonas gingivalis FimA protein on the surface of Streptococcus gordonii.

  1999cited by this paper
• Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.

  1999cited by this paper
• Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens.

  1998cited by this paper
• Invasion of Aortic and Heart Endothelial Cells byPorphyromonas gingivalis

  1998cited by this paper
• Vaginal Immunization with Recombinant Gram‐Positive Bacteria

  1998cited by this paper
• Life Below the Gum Line: Pathogenic Mechanisms ofPorphyromonas gingivalis

  1998cited by this paper
• Porphyromonas gingivalis Fimbriae Mediate Coaggregation with Streptococcus oralis through Specific Domains

  1997cited by this paper
• IgA antibody as a non-inflammatory regulator of immunity.

  1997cited by this paper
• Secretion of Porphyromonas gingivalis fimbrillin polypeptides by recombinant Streptococcus gordonii.

  1997cited by this paper
• Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice.

  1997cited by this paper
• Secretion ofPorphyromonas gingivalisFimbrillin Polypeptides by RecombinantStreptococcus gordonii

  1997cited by this paper
• A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells

  1997cited by this paper
• Identification of murine protective epitopes on the Porphyromonas gingivalis fimbrillin molecule

  1996cited by this paper
• Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii

  1996cited by this paper
• Gram-positive commensal bacteria for mucosal vaccine delivery.

  1996cited by this paper
• Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes.

  1996cited by this paper
• Anti‐inflammatory properties of human serum IgA: induction of IL‐1 receptor antagonist and FcαR (CD89)‐mediated down‐regulation of tumour necrosis factor‐alpha (TNF‐α) and IL‐6 in human monocytes

  1996cited by this paper
• Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization.

  1995cited by this paper
• The colon and rectum as inductor sites for local and distant mucosal immunity.

  1995cited by this paper
• Porphyromonas gingivalis invasion of gingival epithelial cells

  1995cited by this paper
• Immunization of mice by oral colonization with live recombinant commensal streptococci.

  1995cited by this paper
• A peptide, ALTTE, within the fimbrial subunit protein from Porphyromonas gingivalis, induces production of interleukin 6, gene expression and protein phosphorylation in human peripheral blood mononuclear cells.

  1995cited by this paper
• Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats

  1994cited by this paper
• Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis

  1994cited by this paper
• Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces

  1994cited by this paper
• Porphyromonas gingivalis fimbriae and their synthetic peptides induce proinflammatory cytokines in human peripheral blood monocyte cultures.

  1994cited by this paper
• Molecular pathogenesis of periodontal disease

  1994cited by this paper
• Active domains of fimbrillin involved in adherence of Porphyromonas gingivalis.

  1993cited by this paper
• Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization.

  1993cited by this paper
• Expression of a functional Porphyromonas gingivalis fimbrillin polypeptide in Escherichia coli: purification, physicochemical and immunochemical characterization, and binding characteristics

  1993cited by this paper
• Involvement of Porphyromonas gingivalis fimbriae in adherence to Streptococcus gordonii.

  1993cited by this paper
• Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis

  1992cited by this paper
• Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction

  1992cited by this paper
• Immunization with fimbrial protein and peptide protects against Porphyromonas gingivalis-induced periodontal tissue destruction.

  1992cited by this paper
• Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides.

  1992cited by this paper
• Porphyromonas (Bacteroides) gingivalis fimbrillin: size, amino-terminal sequence, and antigenic heterogeneity

  1991cited by this paper
• Combined oral/nasal immunization protects mice from Sendai virus infection.

  1987cited by this paper

• A Narrative Review of Periodontal Vaccines: Hope or Hype?

  2025cites this paper
• Porphyromonas gingivalis Vaccine: Antigens and Mucosal Adjuvants

  2024cites this paper
• From a better knowledge of periodontal disease to Porphyromonas gingivalis target for rheumatoid arthritis disease activity.

  2024cites this paper
• Oral microbiota–host interaction: the chief culprit of alveolar bone resorption

  2024cites this paper
• Periodontal vaccines via plantibodies: Bridging the gap between aspiration and achievement

  2024cites this paper
• Mucosal Vaccination Against Periodontal Disease: Current Status and Opportunities

  2021influential citation
• CpG immunostimulatory oligodeoxynucleotide 1826 as a novel nasal ODN adjuvant enhanced the protective efficacy of the periodontitis gene vaccine in a periodontitis model in SD rats

  2021cites this paper
• Inhibition of experimental periodontitis by a monoclonal antibody against Porphyromonas gingivalis HA2.

  2021cites this paper
• Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy.

  2020cites this paper
• Persistence of Tannerella forsythia and Fusobacterium nucleatum in Dental Plaque: a Strategic Alliance

  2020cites this paper
• Mucosal Vaccines for Oral Disease

  2020cites this paper
• Porphyromonas gingivalis: Immune Subversion Activities and Role in Periodontal Dysbiosis

  2020cites this paper
• Periodontal Bone-Ligament-Cementum Regeneration via Scaffolds and Stem Cells

  2019cites this paper
• Immunization against Porphyromonas gingivalis for Prevention of Experimentally Induced Periodontitis in Rats

  2019cites this paper
• Recombinant fimbriae protein of Porphyromonas gingivalis induces an inflammatory response via the TLR4/NF-κB signaling pathway in human peripheral blood mononuclear cells

  2019cites this paper
• Lactic acid bacteria — promising vaccine vectors: possibilities, limitations, doubts

  2017cites this paper
• Porphyromonas gingivalis infection in gestational diabetes mellitus and survival in tobacco smokers.

  2017cites this paper
• Antibody Titer Against Porphyromonas Gingivalis in Rats with Experimentally Induced Periodontitis

  2017cites this paper
• Periodontal Vaccines: A Sophisticated Treatment Design in the Future?

  2015cites this paper
• Vaccines for periodontal disease: a new hope?

  2015cites this paper
• Gene therapy in dentistry: a review.

  2013cites this paper
• Periodontology: past, present, perspectives.

  2013cites this paper
• Gene therapy in periodontics

  2013cites this paper
• Immunization in Periodontics : A Systematic Review

  2013cites this paper
• Análise da variabilidade de sistema de regulação de dois componentes FimSR e expressão do operon fimA em Porphyromonas gingivalis

  2013cites this paper
• Animal Models in Periodontal Research

  2012cites this paper
• Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen.

  2012cites this paper
• Novel and often bizarre strategies in the treatment of periodontal disease

  2012cites this paper
• Streptococcus cristatus ArcA interferes with Porphyromonas gingivalis pathogenicity in mice.

  2012cites this paper
• Microbial Dynamics and Caries: The Role of Antimicrobials

  2012cites this paper
• Development of mucosal vaccines for avian influenza A virus composed of recombinant Lactococcus lactis and Streptococcus gordonii

  2011cites this paper
• Prophylactic vaccination against periodontal disease: a systematic review of preclinical studies.

  2010cites this paper
• Host immune responses to Porphyromonas gingivalis antigens.

  2010cites this paper
• Vaccines against periodontitis: a forward-looking review

  2010cites this paper
• Consumption of curcumin elevates fecal immunoglobulin A, an index of intestinal immune function, in rats fed a high-fat diet.

  2010cites this paper
• Feasibility and therapeutic strategies of vaccines against Porphyromonas gingivalis

  2010cites this paper
• Production of Monoclonal Antibodies Specific to FimA of Porphyromonas gingivalis and Their Inhibitory Activity on Bacterial Binding

  2009cites this paper
• Toll gates to periodontal host modulation and vaccine therapy.

  2009cites this paper
• Synthesis and Assembly of Porphyromonas gingivalis Fimbrial Protein in Potato Tissues

  2009cites this paper
• Immunoprotective analysis of VhhP2, a Vibrio harveyi vaccine candidate.

  2009cites this paper
• The use of rodent models to investigate host-bacteria interactions related to periodontal diseases.

  2008cites this paper
• Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.

  2007cites this paper
• Vaccination against periodontitis: the saga continues

  2007cites this paper
• Peptide Mapping of a Functionally Versatile Fimbrial Adhesin from Porphyromonas gingivalis

  2007influential citation
• Potential for Immunological and Microbiological Intervention against Porphyromonas gingivalis Infection

  2007cites this paper
• Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants.

  2006cites this paper
• Gene therapy in periodontics: a review and future implications.

  2006cites this paper
• Protective and Destructive Immunity in the Periodontium: Part 2—T-cell-mediated Immunity in the Periodontium

  2006cites this paper
• Commensal bacteria as a novel delivery system for subunit vaccines directed against agents of bioterrorism

  2005cites this paper
• Characterization and applications of Lactobacillus brevis S-layer proteins and evaluation of Lactococcus lactis as a porcine cytokine producer

  2005cites this paper
• Immune responses and vaccination against periodontal infections.

  2005cites this paper
• Evaluation of a monovalent companion animal periodontal disease vaccine in an experimental mouse periodontitis model.

  2005cites this paper
• THE BIOFILM CONCEPT: CONSEQUENCES FOR FUTURE PROPHYLAXIS OF ORAL DISEASES?

  2004cites this paper
• A regulation cascade controls expression of Porphyromonas gingivalis fimbriae via the FimR response regulator

  2004cites this paper
• Immunization with Porphyromonas gingivalis Capsular Polysaccharide Prevents P. gingivalis-Elicited Oral Bone Loss in a Murine Model

  2003cites this paper
• Advances in oral vaccine delivery options

  2003cites this paper
• Virulence factors of Porphyromonas gingivalis are modified by polyphenol oxidase and asparaginase.

  2003cites this paper
• Oral colonization and immune responses to Streptococcus gordonii: potential use as a vector to induce antibodies against respiratory pathogens

  2003cites this paper
• Immunization with the RgpA-Kgp Proteinase-Adhesin Complexes of Porphyromonas gingivalis Protects against Periodontal Bone Loss in the Rat Periodontitis Model

  2002cites this paper
• Engineered Commensal Bacteria as Delivery Systems of Anti-infective Mucosal Protectants

  2002cites this paper
• Teng Periodontium T-cell-mediated Immunity in the − − Protective and Destructive Immunity in the Periodontium : Part 2

  year unknowncites this paper